CompletedPhase 2NCT03083678

Afatinib in Locally Advanced and Metastatic Chordoma

Studying Chordoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Leiden University Medical Center
Principal Investigator
AJ Gelderblom, Prof
Leiden University Medical Center
Intervention
Afatinib(drug)
Enrollment
43 enrolled
Eligibility
18 years · All sexes
Timeline
2018 – 2025

Study locations (3)

Collaborators

Chordoma Foundation · Boehringer Ingelheim

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03083678 on ClinicalTrials.gov

Other trials for Chordoma

Additional recruiting or active studies for the same condition.

See all trials for Chordoma →

← Back to all trials